Brian Strem
Amministratore Delegato presso KIORA PHARMACEUTICALS, INC.
Patrimonio netto: 50 828 $ in data 31/05/2024
Posizioni attive di Brian Strem
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Amministratore Delegato | 26/07/2021 | - |
| Direttore/Membro del Consiglio | 26/07/2021 | - | |
| Presidente | 26/07/2021 | - | |
| Comptroller/Controller/Auditor | 16/06/2022 | - | |
| Direttore Finanziario/CFO | 16/06/2022 | - | |
Okogen, Inc.
 Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Direttore/Membro del Consiglio | 01/06/2015 | - |
| Direttore Finanziario/CFO | - | - | |
| Fondatore | - | - | |
| Segretario Aziendale | - | - | |
Yellowbrick Bio LLC
 Yellowbrick Bio LLC Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Yellowbrick Bio LLC is a company that manufactures ophthalmological pharmaceutical products. The company is based in Solana Beach, CA. The company was founded in 2020 by Brian Matthew Strem. Yellowbrick Bio was acquired by Kiora Pharmaceuticals, Inc. on October 21, 2021 for $7.22 million. | Direttore/Membro del Consiglio | 01/01/2020 | - |
| Fondatore | 01/01/2020 | - | |
| Corporate Officer/Principal | - | - | |
| Bayon Therapeutics, Inc. | Direttore/Membro del Consiglio | - | - |
| Fondatore | - | - |
Storia della carriera di Brian Strem
Formazione di Brian Strem
| University of California, Los Angeles | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Director/Board Member | 4 |
| Founder | 3 |
| Director of Finance/CFO | 2 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Okogen, Inc.
Okogen, Inc. Miscellaneous Commercial ServicesCommercial Services Okogen, Inc. engages in the development of clinical theraphies to serve the needs of adult and children with ocular infections. Its lead candidate, OKG-0301, is a ribonuclease which targets degradation of specific tRNA and miRNA, which leads to inhibiting protein synthesis. It stops viral replication and shortens the duration of infection. The company was founded on July 1, 2016 and is headquartered in Encinitas, CA. | Commercial Services |
Yellowbrick Bio LLC
Yellowbrick Bio LLC Pharmaceuticals: MajorHealth Technology Part of Kiora Pharmaceuticals, Inc., Yellowbrick Bio LLC is a company that manufactures ophthalmological pharmaceutical products. The company is based in Solana Beach, CA. The company was founded in 2020 by Brian Matthew Strem. Yellowbrick Bio was acquired by Kiora Pharmaceuticals, Inc. on October 21, 2021 for $7.22 million. | Health Technology |
| Bayon Therapeutics, Inc. |
- Borsa valori
- Insiders
- Brian Strem
- Esperienza
